Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 208 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Tziomalos, Konstantinos [Clear All Filters]
Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels..
Curr Drug Targets. 8(3), 483-8.
(2007). Impact of managing atherogenic dyslipidemia on cardiovascular outcome across different stages of diabetic nephropathy..
Expert Opin Pharmacother. 11(5), 723-30.
(2010). The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study..
Curr Vasc Pharmacol. 11(5), 779-84.
(2013). Impaired kidney function evaluated with the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation is associated with more severe acute ischemic stroke..
Vasc Med. 22(5), 432-434.
(2017). Implementation of guidelines for the management of arterial hypertension. The impulsion study..
Open Cardiovasc Med J. 3, 26-34.
(2009). IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis..
Arch Med Sci. 7(6), 984-92.
(2011). Increased augmentation index is paradoxically associated with lower in-hospital mortality in patients with acute ischemic stroke..
Atherosclerosis. 236(1), 150-3.
(2014). Increased Sclerostin, but Not Dickkopf-1 Protein, Is Associated with Elevated Pulse Wave Velocity in Hemodialysis Subjects..
Kidney Blood Press Res. 44(4), 679-689.
(2019). An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)..
Hormones (Athens). 16(3), 200-204.
(2017).
(2017).
(2012). JUPITER: major implications for vascular risk assessment..
Curr Med Res Opin. 25(1), 133-7.
(2009).
(2009). Kidney function and estimated vascular risk in patients with primary dyslipidemia..
Open Cardiovasc Med J. 3, 57-68.
(2009). Lack of an association between angiotensin converting enzyme gene polymorphism and peripheral arterial occlusive disease..
Vasc Med. 9(3), 189-92.
(2004). Lack of an association between angiotensin-converting enzyme gene insertion/deletion polymorphism and ischaemic stroke..
Eur Neurol. 51(3), 148-52.
(2004). Left ventricular hypertrophy assessed by electrocardiogram is associated with more severe stroke and with higher in-hospital mortality in patients with acute ischemic stroke..
Atherosclerosis. 274, 206-211.
(2018). Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility..
Endocrine. 44(3), 583-90.
(2013). Lipid lowering agents and the endothelium: an update after 4 years..
Curr Vasc Pharmacol. 10(1), 33-41.
(2012). Lipid-lowering agents and new onset diabetes mellitus..
Expert Opin Pharmacother. 11(12), 1965-70.
(2010). Lipid-lowering agents in the management of nonalcoholic fatty liver disease..
World J Hepatol. 6(10), 738-44.
(2014). Lipoprotein a: where are we now?.
Curr Opin Cardiol. 24(4), 351-7.
(2009). Lipoprotein-associated Phospholipase A2 and Coronary Heart Disease..
Curr Pharm Des. 24(3), 291-296.
(2018). Liver iron content determination by magnetic resonance imaging..
World J Gastroenterol. 16(13), 1587-97.
(2010).
(2012).